Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization.

Cassone M, Mantey J, Perri MB, Gibson K, Lansing B, McNamara S, Patel PK, Cheng VCC, Walters MS, Stone ND, Zervos MJ, Mody L.

Clin Infect Dis. 2018 Aug 31;67(6):861-868. doi: 10.1093/cid/ciy115. Erratum in: Clin Infect Dis. 2018 Aug 31;67(6):987.

2.

Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Ayau P, Bardossy AC, Sanchez G, Ortiz R, Moreno D, Hartman P, Rizvi K, Prentiss TC, Perri MB, Mahan M, Huang V, Reyes K, Zervos MJ.

Int J Infect Dis. 2017 Aug;61:3-6. doi: 10.1016/j.ijid.2017.05.010. Epub 2017 May 19.

3.

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.

Arshad S, Huang V, Hartman P, Perri MB, Moreno D, Zervos MJ.

Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25.

4.

Nosocomial Outbreak of a Novel Extended-Spectrum β-Lactamase Salmonella enterica Serotype Isangi Among Surgical Patients.

Suleyman G, Tibbetts R, Perri MB, Vager D, Xin Y, Reyes K, Samuel L, Chami E, Starr P, Pietsch J, Zervos MJ, Alangaden G.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):954-61. doi: 10.1017/ice.2016.85. Epub 2016 Apr 25.

PMID:
27108715
5.

Reply to "Urinary Tract Infections: Resistance Is Futile".

Kenney RM, Cole KA, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2598. doi: 10.1128/AAC.00011-16. Print 2016 Apr. No abstract available.

6.

Impact of Intervention Measures on MRSA Clonal Type and Carriage Site Prevalence.

Cassone M, McNamara SE, Perri MB, Zervos M, Mody L.

mBio. 2016 Mar 8;7(2):e00218. doi: 10.1128/mBio.00218-16. No abstract available.

7.

Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections.

Cole KA, Kenney RM, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL.

Antimicrob Agents Chemother. 2015 Dec;59(12):7362-6. doi: 10.1128/AAC.01817-15. Epub 2015 Sep 14.

8.

Transmission of infection to liver transplant recipients from donors with infective endocarditis: lessons learned.

Miceli MH, Gonulalan M, Perri MB, Samuel L, Al Fares MA, Brown K, Bruno DA, Zervos M, Ramesh M, Alangaden G.

Transpl Infect Dis. 2015 Feb;17(1):140-6. doi: 10.1111/tid.12330. Epub 2015 Jan 14.

9.

Evaluation of in vitro susceptibility trends to vancomycin and daptomycin by strain type of Staphylococcus aureus causing bloodstream infections.

Shoyinka A, Moreno D, Arshad S, Perri MB, Donabedian SM, Jacobsen G, Hartman P, Ziegler R, Huang V, Zervos MJ.

J Glob Antimicrob Resist. 2014 Dec;2(4):280-285. doi: 10.1016/j.jgar.2014.05.002. Epub 2014 Jun 7.

PMID:
27873688
10.

Methicillin-resistant Staphylococcus aureus: site of acquisition and strain variation in high-risk nursing home residents with indwelling devices.

Gibson KE, McNamara SE, Cassone M, Perri MB, Zervos M, Mody L; Targeted Infection Prevention Study Team, Ann Arbor, Michigan.

Infect Control Hosp Epidemiol. 2014 Dec;35(12):1458-65. doi: 10.1086/678599. Epub 2014 Nov 5.

11.

Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.

Marchaim D, Pogue JM, Tzuman O, Hayakawa K, Lephart PR, Salimnia H, Painter T, Zervos MJ, Johnson LE, Perri MB, Hartman P, Thyagarajan RV, Major S, Goodell M, Fakih MG, Washer LL, Newton DW, Malani AN, Wholehan JM, Mody L, Kaye KS.

J Clin Microbiol. 2014 May;52(5):1617-21. doi: 10.1128/JCM.00001-14. Epub 2014 Mar 5.

12.

Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus.

Haque NZ, Arshad S, Peyrani P, Ford KD, Perri MB, Jacobsen G, Reyes K, Scerpella EG, Ramirez JA, Zervos MJ.

J Clin Microbiol. 2012 May;50(5):1640-4. doi: 10.1128/JCM.06701-11. Epub 2012 Feb 15.

13.

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.

Clin Infect Dis. 2012 Jan 1;54(1):51-8. doi: 10.1093/cid/cir764. Epub 2011 Nov 21.

PMID:
22109947
14.

Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.

Moore CL, Lu M, Cheema F, Osaki-Kiyan P, Perri MB, Donabedian S, Haque NZ, Zervos MJ.

Antimicrob Agents Chemother. 2011 Oct;55(10):4581-8. doi: 10.1128/AAC.00115-11. Epub 2011 Aug 8.

15.

Commensal Escherichia coli isolate resistant to eight classes of antimicrobial agents in the United States.

Krueger AL, Folster J, Medalla F, Joyce K, Perri MB, Johnson L, Zervos M, Whichard JM, Barzilay EJ.

Foodborne Pathog Dis. 2011 Feb;8(2):329-32. doi: 10.1089/fpd.2010.0619. Epub 2010 Oct 25.

PMID:
20973731
16.

Characterization of vancomycin-resistant Enterococcus faecium isolated from swine in three Michigan counties.

Donabedian SM, Perri MB, Abdujamilova N, Gordoncillo MJ, Naqvi A, Reyes KC, Zervos MJ, Bartlett P.

J Clin Microbiol. 2010 Nov;48(11):4156-60. doi: 10.1128/JCM.02346-09. Epub 2010 Aug 25.

17.

Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia.

Shorr AF, Haque N, Taneja C, Zervos M, Lamerato L, Kothari S, Zilber S, Donabedian S, Perri MB, Spalding J, Oster G.

J Clin Microbiol. 2010 Sep;48(9):3258-62. doi: 10.1128/JCM.02529-09. Epub 2010 Jul 14.

18.

Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.

Moore CL, Hingwe A, Donabedian SM, Perri MB, Davis SL, Haque NZ, Reyes K, Vager D, Zervos MJ.

Int J Antimicrob Agents. 2009 Aug;34(2):148-55. doi: 10.1016/j.ijantimicag.2009.03.004. Epub 2009 Apr 25.

PMID:
19394801
19.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.

Chua T, Moore CL, Perri MB, Donabedian SM, Masch W, Vager D, Davis SL, Lulek K, Zimnicki B, Zervos MJ.

J Clin Microbiol. 2008 Jul;46(7):2345-52. doi: 10.1128/JCM.00154-08. Epub 2008 May 28.

20.

Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations.

Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL; Legionella Study Group.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):818-24. Epub 2007 Jun 5.

PMID:
17564984
21.

Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA).

Haque NZ, Davis SL, Manierski CL, Vager D, Donabedian SM, Perri MB, Sabbagh R, Cheema F, Zervos MJ.

Int J Antimicrob Agents. 2007 Jul;30(1):72-7. Epub 2007 Apr 10.

PMID:
17428640
22.

Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.

Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ.

J Clin Microbiol. 2007 Jun;45(6):1705-11. Epub 2007 Mar 28.

23.

Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States.

Donabedian SM, Perri MB, Vager D, Hershberger E, Malani P, Simjee S, Chow J, Vergis EN, Muder RR, Gay K, Angulo FJ, Bartlett P, Zervos MJ.

J Clin Microbiol. 2006 Sep;44(9):3361-5.

24.

Plasmid content of a vancomycin-resistant Enterococcus faecalis isolate from a patient also colonized by Staphylococcus aureus with a VanA phenotype.

Flannagan SE, Chow JW, Donabedian SM, Brown WJ, Perri MB, Zervos MJ, Ozawa Y, Clewell DB.

Antimicrob Agents Chemother. 2003 Dec;47(12):3954-9.

25.

Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food.

Donabedian SM, Thal LA, Hershberger E, Perri MB, Chow JW, Bartlett P, Jones R, Joyce K, Rossiter S, Gay K, Johnson J, Mackinson C, Debess E, Madden J, Angulo F, Zervos MJ.

J Clin Microbiol. 2003 Mar;41(3):1109-13.

26.

In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.

Perri MB, Hershberger E, Ionescu M, Lauter C, Zervos MJ.

Diagn Microbiol Infect Dis. 2002 Apr;42(4):269-71.

PMID:
12007445
27.

Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci.

Bostic GD, Perri MB, Thal LA, Zervos MJ.

Diagn Microbiol Infect Dis. 1998 Feb;30(2):109-12.

PMID:
9554178
28.

Antimicrobial resistance in enterococci isolated from Turkey flocks fed virginiamycin.

Welton LA, Thal LA, Perri MB, Donabedian S, McMahon J, Chow JW, Zervos MJ.

Antimicrob Agents Chemother. 1998 Mar;42(3):705-8.

29.

Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.

Silverman J, Thal LA, Perri MB, Bostic G, Zervos MJ.

J Clin Microbiol. 1998 Mar;36(3):830-2.

30.

Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium.

Bonilla HF, Perri MB, Kauffman CA, Zervos MJ.

Diagn Microbiol Infect Dis. 1996 Jul;25(3):127-31.

PMID:
8902408
31.

Characterization of antimicrobial resistance in enterococci of animal origin.

Thal LA, Chow JW, Mahayni R, Bonilla H, Perri MB, Donabedian SA, Silverman J, Taber S, Zervos MJ.

Antimicrob Agents Chemother. 1995 Sep;39(9):2112-5.

32.

Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis.

Chow JW, Thal LA, Perri MB, Vazquez JA, Donabedian SM, Clewell DB, Zervos MJ.

Antimicrob Agents Chemother. 1993 Nov;37(11):2474-7.

33.

Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.

Vazquez J, Perri MB, Thal LA, Donabedian SA, Zervos MJ.

J Antimicrob Chemother. 1993 Nov;32(5):715-21.

PMID:
8125836
34.

In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci.

Perri MB, Chow JW, Zervos MJ.

Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):151-5.

PMID:
8243036
35.

Mobilization of the penicillinase gene in Enterococcus faecalis.

Chow JW, Perri MB, Thal LA, Zervos MJ.

Antimicrob Agents Chemother. 1993 May;37(5):1187-9.

36.

Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.

Thal LA, Vazquez J, Perri MB, Beckley A, Donabedian S, Kaatz GW, Patterson JE, Zervos MJ.

J Antimicrob Chemother. 1993 Jan;31(1):182-5. No abstract available.

PMID:
8444668
37.

Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance.

Thal LA, Chow JW, Patterson JE, Perri MB, Donabedian S, Clewell DB, Zervos MJ.

Antimicrob Agents Chemother. 1993 Jan;37(1):134-7.

Supplemental Content

Loading ...
Support Center